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Introduction
Amyloid precursor protein (APP) belongs to a family of integral type I membrane proteins highly expressed in the central nervous system (CNS) and undergoes sequential cleavages by β-and γ-secretases (De Strooper et al. 2010) , generating β-amyloid (Aβ) peptides that are critically involved in the pathogenesis of Alzheimer's disease (AD) (Hardy 2006; Rovelet-Lecrux et al. 2006) . APP is distributed in both presynaptic terminals (Koo et al. 1990; Sisodia et al. 1993 ) and postsynaptic dendrites (Yamazaki et al. 1995; Hoe et al. 2009 ) and plays a critical role in synaptic plasticity (Seabrook et al. 1999; Ring et al. 2007; Weyer et al. 2011) . While previous studies have mostly focused on the pathological significance of APP as a precursor of Aβ, much less is known about physiological roles of APP; how it regulates synaptic and particularly neural network activity that forms a critical interface between cellular activity and information processing is largely unknown. Given that we have been interested in this point and have shown that APP indeed plays an important role in the formation, maintenance, and function of synapses (Yang et al. 2007; Wang et al. 2009; Yang et al. 2009) , it is imperative to elucidate whether network activity can be regulated by APP.
UP-DOWN states (UDSs), slow (<1 Hz) oscillations in the neocortex, represent a critical aspect of neocortical network and systemic functions; they are driven by local recurrent excitation and inhibition and occur synchronously among all pyramidal neurons in cortical regions including the prefrontal cortex (PFC) (Steriade et al. 1993b; Sanchez-Vives and McCormick 2000; Haider and McCormick 2009; Sanchez-Vives et al. 2010) . The entire cortical network alternates between depolarizing (i.e., UP) and hyperpolarizing (i.e., DOWN) states during slow-wave sleep (SWS) and some types of anesthesia (Steriade et al. 1993c) . Although anesthesia-induced slow oscillation appears more regular than during SWS (Steriade et al. 1993c; Wolansky et al. 2006; Chauvette et al. 2011) , experiments on anesthetized rodents revealed a slow cortical activity similar to that observed during natural SWS (Luczak et al. 2007; Sharma et al. 2010) , which has been shown to be strongly linked to synaptic activity (Buzsaki and Draguhn 2004) and involved in long-term memory consolidation in neocortex (Marshall and Born 2007; Crunelli and Hughes 2010) . Induction of slow oscillation-like potentials (0.75 Hz) over the PFC of participants during early night SWS resulted in a greater benefit on overnight retention for information learned prior to sleep (Marshall et al. 2004; Marshall et al. 2006) , suggesting a critical role of PFC slow oscillation in memory consolidation during SWS.
In this study, we evaluated the role of APP in PFC slow oscillation in SWS-like condition by recording in vivo UDS in anaesthetized wild-type (WT) and APP −/− mice to address the following questions: are in vivo spontaneous and rhythmic UP states altered in the PFC of APP −/− mice in SWS-like condition and are alterations intrinsic to PFC? Second, what is the relative role of changes in excitatory versus inhibitory system? Third, what molecular and cellular processes lead to prolonged UP states and thus hyperexcitation in the absence of APP? Crucially, we observed an increase in spontaneously occurring UP-state duration in the animals lacking APP, and that this alteration involves changes in GABAergic, but not glutamatergic, signaling in PFC neurons.
Materials and Methods

Animals and Surgery
All experimental procedures were approved by the South China Normal University Animal Care and Use Committee. APP −/− mice (Zheng et al. 1995) and C57BL/6J WT littermates, obtained from the Model Animal Research Center of Nanjing University. GAD67 +/GFP mice (Tamamaki et al. 2003) were gift from Dr Yuqiang Ding at the School of Medicine of Tongji University. APP/PS1 (B6C3-Tg [APPswe, PSEN1dE9] 85Dbo/J) double transgenic mice (Jankowsky et al. 2001) were obtained from Model Animal Research Center of Nanjing University. Mice were raised with free access to food and water and were kept on a 12 h light-dark cycle. Both male and female mice (APP −/− and WT mice at 1-2 months; APP/PS1 and WT at 2-5 months) were used in all experiments unless otherwise indicated. Littermates were used for comparison. Animals were anesthetized by intraperitoneal (IP) injection with chloral hydrate (400 mg/kg) (Lewis and O'Donnell 2000) , and an additional 1/3 dose of chloral hydrate was used whenever necessary during the experiment to maintain anesthesia at a level where tail pinching did not evoke a withdrawal reflex. Animals were self-breathing, and body temperature was maintained at 37 ± 0.5°C by a Homeothermic Heating Device (Harvard Apparatus). Mice were positioned in a stereotaxic apparatus (RWD Life Science) for surgery, intracellular recordings, and drug injection. Bilateral craniotomies (~1 mm in diameter) were performed +1.78 mm anterior to the bregma, directly above the PFC. Cisternal cerebrospinal fluid (CSF) drainage was performed to relieve brain pulsations. The dura overlying both hemispheres was dissected and retracted, and the craniotomies were filled with warm sterile saline (0.9% NaCl) and petroleum jelly (Chauvette et al. 2011 ).
In Vivo UDS Recordings and Analysis
Sharp Electrode Recordings Intracellular recordings were obtained from a PFC region located +1.78 mm anterior to the bregma, ±0.5 mm lateral to the midline. Sharp microelectrodes were made using borosilicate glass capillaries (1B100F-4; WPI, Sarasota, FL), with a resistance ranging from 60 to 90 MΩ (P-97 Microelectrode Puller; Sutter Instrument Co.). The recording electrode, filled with 2 M K-acetate, was advanced with a mechanical micromanipulator (MX-2; Narishige, Tokyo, Japan) into PFC layers IV and V (Paxinos and Franklin 2001; Olsen et al. 2012) as confirmed with lesions observed after brain fixation. The microelectrode was left in place for 20-30 min and then slowly advanced through the PFC until a neuron was impaled. Only recordings fulfilling all of the following criteria were included in the study: 1) resting membrane potential of at least −50 mV, 2) all-point histogram of membrane potential showing bimodal Gaussian distribution, 3) all parameters remaining stable for at least 10 min. A total of 10 min of spontaneous activity was collected from each recording. The recorded signal was amplified by an electrometer amplifier Duo 773 (WPI), sampled at 16.6 kHz using a Micro1401 Analog Digital converter (CED Ltd, Cambridge, UK), and recorded and analyzed with Spike2 software (Cambridge Electronic Design, Cambridge, UK).
UDS Analysis
Membrane potential fluctuations typical of UDS were algorithmically detected using the strategy proposed for characterizing UP and DOWN states in electrophysiological data (Seamari et al. 2007; Constantinople and Bruno 2011; Reig et al. 2015) . Unless otherwise stated, only UP states that were at least 0.2 s in duration were considered. The standard deviation (SD) of the membrane potential in the UP and DOWN states was calculated as reported (Shu et al. 2003a) . Briefly, a Gaussian function was fitted to the distributions of membrane potentials during UP and DOWN states after the removal of the depolarizing phase of action potentials with a median filter.
In Vivo Extracellular Recordings and Analysis
Extracellular Recording in Anesthetized Mice Extracellular action potentials (spikes) of individual neurons, including multiple-unit activities (MU) in the PFC, were captured using glass electrodes (0.5-1.0 MΩ) containing 0.5 M NaCl. Raw data were bandpass filtered (0.1-10 000 Hz) and amplified (A-M Systems, Model 3000) before acquisition. 
Western Blotting Procedures
Mouse brains were homogenized with micro tissue grinders (Kimble) in 2 mL tubes, using lysis buffer containing 50 mM Tris pH 7.5, 150 mM NaCl, 5 mM EDTA pH 8.0, 1% SDS, and protease inhibitor (Complete Mini; Roche). After 1 min homogenization, cellular debris was removed by centrifugation at 13 600 × g for 10 min at 4°C, and supernatant was collected for denaturation for 20 min at 75°C. Tissue lysates were subjected to SDS-PAGE (Bio-Rad) and transferred to nitrocellulose membranes. The membranes were blocked for 0.5 h using 5% non-fat dry milk in Tris-buffered saline (TBS) containing 0.5% Tween-20 (TBST), then probed with specific primary antibodies against GABA B1 R (Neuromab, 75-183), GABA B1a R (Santa Cruz, sc-7340), GABA B2 R (Neuromab, Millipore, . Anti γ-tubulin antibody (Sigma, T6557) was used as loading control. After 3 washes with TBST, HRP-labeled secondary antibody (CWS) application was performed at room temperature (RT) for 1 h using 5% milk in TBST followed by 3 additional washes with TBST. Bands were visualized using Immobilon Western ECL system (CWS) and analyzed with Gel Pro Analysis software ).
Immunohistochemistry
Brains were removed, perfused transcardially with saline and 4% paraformaldehyde, postfixed for 3 h, and sucrose-protected in 30% sucrose overnight and then sectioned at 20 μm using freezing microtome (Leica). Free-floating sections were washed 3 times with PBS and incubated with rabbit anti-glutamine synthetase (GS) antibody diluted in PBS + 10% Triton X-100 + 3% BSA. After primary antibody incubation for 24 h at 4°C, sections were washed in PBS 3 times for 10 min each and incubated with the secondary antibody (CWS) diluted in PBS + 10% Triton X-100 + 3% BSA for 1 h at RT. Sections were washed, incubated with 4, 6-diamidino-2-phenylindole dihydrochloride (DAPI) (Vectashield) for 15 min at RT, washed and mounted onto gelatin-coated slides, and then imaged on a fluorescence microscope.
Quantitative Real-Time PCR Total RNA was extracted using Trizol reagent and treated with RNase-free DNase I (TaKaRa, Dalian, China) at 37°C for 1 h. Reverse transcription was then carried out on 2 μg total RNA with 200 ng random primers using a cDNA synthesis kit (TaKaRa, Dalian, China) according to the manufacturer's protocol. To investigate the expression of GABA B2 R genes in the PFC of WT and APP −/− mice, the following gene-specific primers were used: APP F-primer, (5′-3′) CCAAGAGGTCTACCCTGAACT GC; APP R-primer, (5′-3′) AGGCAACGGTAAGGAATCACG; GABA B2 R F-primer, (5′-3′) GGA AACCCGCAATGTGAGC; GABA B2 R R-primer, (5′-3′) GGCACAAACACCAGGCAGAG; β-actin F-primer (5′-3′) GTGACGTTGACATCCGTAAAGA; β-actin R-primer (5′-3′) TGGTGCCTCTTGCTCAGTTTGT. Amplification was monitored in real-time with the MiniOpticonTM Real-Time PCR System (Bio-Rad, Shanghai, China). Quantitative real-time PCR (RT-PCR) products were validated by determining melt curves at the end of each run, by gel electrophoresis, and by sequencing. Quantification of normalized gene expression was performed by the comparative cycle threshold (C T ) method (Muller et al. 2002) . Statistical analysis was performed on 2 −ΔΔCt values.
Slice Preparation
Slices were prepared from P25-35 WT mice using a Leica VT 1000S tissue slicer with ice-cold oxygenated solution containing (in millimolars) 210 sucrose, 3.0 KCl, 0.75 CaCl 2 , 3.0 MgSO 4 , 1.0 NaH 2 PO 4 , 26 NaHCO 3 , and 10 glucose, saturated with 95% O 2 and 5% CO 2 . Coronal slices of PFC, including the prelimbic area, were cut at 350 μm and kept in artificial CSF (aCSF) containing (in millimolars) 124 NaCl, 3.0 KCl, 1.5 CaCl 2 , 1.3 MgSO 4 , 1.0 NaH 2 PO 4 , 26 NaHCO 3 , and 20 glucose, gassed with 95% O 2 -5% CO 2 at RT. Slices were allowed to recover for at least 1 h before any recording. A slice was transferred to a submerged-type chamber exposed to aCSF flowing at a rate of 2-3 mL/min. Recordings were performed between 32°C and 34°C.
Whole-Cell Patch-Clamp Recording
Patch pipettes were pulled from borosilicate glass capillaries (World Precision Instruments) and filled with internal solution (pH 7.2; 280-290 mOsm) composed of (in millimolars) 100 Cs methanesulfonate, 5 CsCl, 10 HEPES, 2 MgCl 2 , 1 CaCl 2 , 11 BAPTA, 4 ATP, 0.4 GTP (mIPSC recording); 100 Cs methanesulfonate, 10 NaCl, 10 TEA-Cl, 1 MgCl 2 , 10 EGTA, 40 HEPES, 2 ATP, 0.3 GTP, 4 QX-314 (puff recording). A Multiclamp 700B amplifier (Molecular Devices) was used for the recording. The access resistance was monitored throughout each experiment, and only recordings with stable access resistance that held current for at least 3 min were used. Access resistance was not compensated. CNQX (20 μM), APV (50 μM), strychnine (10 μM) and 1 μM TTX were added to the aCSF to block AMPA receptors, NMDA receptors, GlyRs, and voltage-gated sodium channels, respectively. All data were acquired and analyzed using pCLAMP (Molecular Devices). Data were digitized at 10 kHz and filtered at 1 kHz for subsequent analyses.
Brain Homogenate Puff Assay
We performed brain homogenate puff assays as reported (Wu et al. 2014) . Briefly, 3 pairs of 1-to 2-month old WT and APP
−/−
littermates and 4 pairs of 2-3 months old WT and APP/PS1 littermates were killed, and the brain quickly removed and washed in ice-cold PBS. PFCs were dissected, weighed, and flash-frozen in liquid nitrogen and then stored in a −80°C freezer. To make PFC homogenate, 2 freeze-thaw cycles were performed to break the cell membrane before adding 20 μL bath solution per milligram tissue into the tube, followed by 1 min sonication on ice. The homogenate was centrifuged for 5 min at 5000 × g, and supernatant was then aliquoted and stored at −20°C. The stored PFC supernatant was further diluted using aCSF (1:100) for puffing experiments. Puffs were of 200 ms duration at 50 psi and were delivered using a Picospritzer (Parker Instrumentation).
Microinjection and IP Injection
Drugs were prepared as stocks and stored at −20°C. GABA B R agonist, Baclofen (Bac) (Sigma), was dissolved in saline at 100 µM. Tiagabine (TGB) (Meilun) was dissolved in absolute ethanol at 266 mM and then diluted with saline to 80 mM at use. Aβ 1-42 (Abcam) was dissolved in DMSO at 10 µM and then diluted with saline to 10 nM and 200 pM at use. After recording intracellular baseline activity for 10 min, drugs were focally microinjected using a syringe infusion/withdrawal pump (53210, Stoelting) into the PFC through a glass pipette (tip diameter: 5-10 µm) at an injection rate of 0.5 µL/min for 8 min. Reagents microinjected included Bac (100 µM, 1 µL), TGB (80 mM, 1 µL), and Aβ (10 nM, 4 µL; 200 pM, 4 µL). For chronic treatments, TGB was intraperitoneally administrated once daily at a dose of 5 mg/kg for 1 week.
Behavior
Social interaction testing was performed as described (Yizhar et al. 2011) in male mice. All data were collected in an automated manner by the video-tracking apparatus and software (Zhenhua, Anhui province, China) for all test phases. Habituate the test mice for at least 1 h before testing in the test room. Each social interaction test was composed of 2 150 -s phases, separated by a duration of 30 s, either with or without the target mouse present in the interaction zone. After completing all test sessions for the cohort, data were analyzed. The social interaction ratio was obtained by dividing the time spent in the interaction zone when the target was present by the time spent in the interaction zone when the target was absent.
Statistical Analysis
Data were analyzed using two-way analysis of variance with the Bonferroni post hoc test, two-sample two-tailed Student's t-test, or paired-sample student's t-test, as appropriate, with P < 0.05 considered statistically significant. Data are presented as mean ± SEM.
Results
In Vivo Spontaneously Occurring UP States are Longer in PFC of APP −/− Mice To evaluate possible network abnormality during SWS-like condition caused by the absence of APP, spontaneously generated UP/DOWN states were measured in PFC of chloral hydrate anesthetized mice by intracellular recordings from pyramidal neurons within layers IV and V (Fig. 1A) . We observed a significantly lengthened UP-state duration in APP , 0.49 ± 0.01 Hz, P = 0.03). In comparison, UDS step, the difference in membrane potential between the UP and DOWN state, was not changed by the absence of APP (Fig. 1I) We next tested whether the increase in UP-state duration might be a result of defects in the balance of recurrent excitation and inhibition (Shu et al. 2003b) . Because it has already been shown that activation of GABA B R contributes to the termination of UP states (Mann et al. 2009 ), we evaluated whether impaired GABA B R-mediated inhibition underlies prolonged UP-state duration in APP −/− PFC. We examined the effect of intraventricular administration of a specific GABA B R agonist, baclofen (Bac), on in vivo intracellularly recorded UP states in WT and APP −/− PFC (Fig. 2) . We found that the difference in UP-state duration between WT and APP −/− PFC was abrogated by intraventricular Bac ( Fig (before: −64 ± 4.45 mV; after: −78.23 ± 2.46 mV; δ = 14.23 ± 1.99 mV; P = 0.006) but not in WT (before: −61.02 ± 2.63 mV; after: −61.58 ± 3.32 mV; δ = 0.56 ± 0.69 mV; P = 0.9) PFC (Fig. 2D) .
Although UP states are generated intrinsically in the neocortex (Steriade et al. 1993b; Sanchez-Vives and McCormick 2000; Rigas and Castro-Alamancos 2007) , they can recruit cortical targets, such as, for example, the thalamus (Steriade et al. 1993a; Rigas and Castro-Alamancos 2007) and the striatum (Cowan and Wilson 1994) . It is therefore important to know whether prolonged UP states alterations in APP −/− PFC are intrinsic to neocortex. We next addressed this question by focal microinjection of Bac into PFC obtained essentially the same effect of Bac on UP-state duration ( Supplementary Fig. 1 ), suggesting that alterations in UP-state duration seen in APP −/− are generated intrinsically in the PFC. We also tested the effect of focally injected an inhibitor of GABA uptake transporter 1 (GAT1), TGB, into the PFC of APP −/− and WT mice to enhance the endogenous extracellular GABA concentration (Fig. 3) . Because focal microinjection around an intracellular recording site causes electrode drifting, we used extracellular recordings to evaluate role of TGB on UP-state duration. In separate experiments, we confirmed that the UP state observed by intracellular recording corresponds to a period of burst spikes from extracellular MUs (Fig. 3A) , as defined previously (Shu et al. 2003a; Hays et al. 2011) . Indeed, similar to the results from intracellular recordings, extracellular UP-state duration was increased in APP −/− PFC compared with WT controls (Fig. 3B-D) (WT, 0.72 ± 0.05 s; APP −/− , 1.09 ± 0.23 s; P = 0.04), while DOWN-state duration was unchanged (Fig. 3E) (WT, 1.60 ± 0.14 s; APP −/− , 1.41 ± 0.17 s; P = 0.40). However, the increase in extracellular GABA concentration by focal microinjection of TGB significantly reduced the UP-state duration compared with a saline control in APP −/− mice (APP −/− Ctrl, 1.13 ± 0.16 s; 4 min after TGB, 0.77 ± 0.07 s, P = 0.04) but not in WT mice (WT Ctrl, 0.79 0.37 ± 0.07 s; 4 min after TGB, 0.82 ± 0.09 s, P = 0.86) and the UPstate duration difference between WT and APP −/− vanished (P = 0.69) (Fig. 3B, C, F) . The results are suggestive of reduced GABAergic or enhanced glutamatergic activity in APP −/− mice in mediating the PFC network activity. It has been reported that physiological concentration of Aβ is 10 nM (Priller et al. 2006 ). Aβ at 200 pM has been shown to be beneficial to synaptic functions (Puzzo et al. 2008) . We thus tested if abnormal UP-state duration in APP −/− mice could be attributed to a loss of Aβ physiological role. After 30 min baseline extracellular recording of UDS in the PFC of APP −/− mice, 200 pM or 10 nM Aβ was focally injected into PFC. UP-state duration was compared between saline control and Aβ-treated mice. No significant differences were observed after Aβ injection as compared with vehicle control (Fig. 3G-I ), suggesting that abnormal UP-state duration in APP −/− mice was not due to a lack of physiological role of Aβ.
GABA Concentration Is Reduced in the PFC of APP −/−
Mice Data thus far suggest that the hypofunction of GABAergic transmission in the presence of Bac and TGB might result from insufficient GABA levels in the synaptic cleft of APP −/− mice. In addition, the effect of TGB to reduce UP-state duration was significantly larger in APP −/− compared with WT mice, suggestive of reduced extracellular GABA content in APP −/− mice. We next evaluated whether APP deficiency does indeed lead to reduced GABA, including intracellular and extracellular, content in the PFC utilizing an electrophysiological assay developed to evaluate GABA concentration in brain homogenate (Wu et al. 2014 ) by taking the supernatant of PFC from 3 pairs of WT and APP −/− mice (Fig. 4A) . When puffing aCSF onto PFC pyramidal neurons of WT or APP −/− slice, we did not observe any current (data not shown). While puffing 20 μM GABAevoked large outward currents in pyramidal neurons of WT PFC that could be blocked by a GABA A R antagonist, 50 μM GABAzine (Fig. 4B) . Similarly, puffing PFC supernatant of WT mice resulted in similar currents in WT pyramidal neurons, which were blocked by GABAzine as well (Fig. 4C) . We then compared GABA current in PFC pyramidal neurons of WT mice by puffing PFC supernatant of either WT or APP −/− mice ( Fig. 4D ) and found it to be significantly reduced in the latter (Fig. 4E ) (WT, 86 ± 5.57 pA; APP −/− , 68.23 ± 5.03 pA; P = 0.03),
suggesting that the PFC of APP −/− mice has a lower GABA concentration than that in WT mice. and WT mice (Fig. 4F) . Together, these results suggest that impaired GABA content in the PFC of APP −/− mice might be attributed to alterations in GABA production rather than reduction in the total number of GABAergic neurons.
GS Protein Levels are Reduced in APP −/− PFC
We next determined whether the reduction in PFC GABA content was due to impairment in GABA synthesis and metabolism. The glutamate/glutamine cycle by which glutamate converted into glutamine by GS (Pines et al. 1992; Arriza et al. 1994 ) is a major regulator of glutamate and GABA metabolism (Bak et al. 2006) . Disrupting the glutamate-glutamine cycle has been shown to reduce hippocampal GABA neurotransmitter pools (Rae et al. 2003) . Numerous other proteins, including specific GABA transporters (Ikegaki et al. 1994; Buddhala et al. 2009 ), rate-limiting GABA-synthesizing enzyme GAD, and GABA transferase (GABA-T) which are enzymes responsible for the degradation of GABA, have been shown to play vital role in the production of GABA (Fenalti et al. 2007 ). We then tested expression levels of above proteins involved in GABA synthesis and catabolism and only observed significantly reduced GS, but not other, protein levels in PFC of APP −/− compared with WT ( Fig. 5A-B) . Immunofluorescent staining using anti-GS antibody confirmed a reduction of GS expression in APP −/− PFC compared with WT (Fig. 5C ).
To examine if decrease in GS levels might potentially reduce GABA neurotransmitters and thus alter inhibitory synaptic strength, we compared miniature inhibitory postsynaptic current (mIPSC) in brain slices containing PFC from WT or APP −/− mice (Fig. 5D ). In line with a reduction in GABA content in the PFC, we observed a significantly reduced mIPSC frequency but not amplitude in APP −/− compared with WT controls (Fig. 5E-F) , likely resulting from insufficient GABA production and synaptic availability due, at least in part, to reduction in GS-mediated GABA synthesis.
GABA B R Levels are Changed in the PFC of APP −/− Mice
We noted that both Bac and TGB treatment decreased the UPstate duration in APP −/− and diminished the UP-state duration Each value represents the mean ± SEM. *P < 0.05, **P < 0.01; two-way analysis of variance with the Bonferroni post hoc test.
difference in between WT and APP −/− PFC, suggesting that sensitivity to GABA B agonist might be increased in APP −/− mice. We therefore examined whether APP deletion leads to altered GABA B R protein levels in PFC. Functional GABA B Rs are heterodimers of 2 proteins, GABA B1 and GABA B2 , the presence of both being essential for GABA B R activity (Gassmann and Bettler 2012) ; thus, we measured levels of both GABA B1 R and GABA B2 R. Strikingly, consistent with our observation of increased sensitivity of postsynaptic Bac in APP −/− PFC, we found that expression levels of GABA B1 R and GABA B2 R were markedly upregulated in the PFC of APP −/− mice ( Fig. 6A-B) .
Because GABA B1a R and GABA B1b R, the 2 subunit isoforms of GABA B1 R, are localized in the presynaptic and postsynaptic compartment, respectively, and play different roles (Vigot et al. 2006) , we next measured whether the presynaptic GABA B1a R isoform were similarly upregulated in APP −/− mice.
However, we found that GABA B1a R levels were not changed in the PFC of APP −/− compared with WT mice (Fig. 6A-B) .
Moreover, GABA A R levels were identical in APP −/− and WT PFC (Fig. 6A-B) .
To test whether GABA B R is regulated at the transcriptional or posttranscriptional level, we performed RT-PCR but did not detect any difference in GABA B R mRNA content between WT and APP −/− PFC (Fig. 6C ). This suggests that GABA B R is regulated posttranscriptionally by APP. This increase in GABA B R levels may be a primary change caused by the loss of APP. Alternatively, it could be secondary to the reduction of GABA, which causes a homeostatic increase in its GABA B R levels (Hartman et al. 2006) . To distinguish these 2 possibilities, we next tested whether chronic treatment with TGB to increase GABA amount in the synaptic cleft would rescue GABA B R levels in APP −/− PFC. GABA B1 R levels were measured after IP injection of TGB for 7 consecutive days, and significant reduced GABA B1 R levels were observed in TGB-treated APP −/− PFC compared with saline controls (Fig. 6D) , suggesting that upregulated GABA B R expression might be secondary to GABA reduction due to impairment in GS expression and function. Postsynaptic GABA B R, activates G-protein-coupled inwardlyrectifying potassium channels (GIRKs), which hyperpolarizes the membrane potential via heterotrimeric G-protein (Luscher et al. 1997; Luscher and Slesinger 2010; Betke et al. 2012) . We thus tested whether APP deficiency leads to altered G α(o) , G β and GIRK2 protein expression but found levels of these proteins in PFC to be unaffected by APP deficiency (Fig. 6E-F) . Therefore, the observed protein expression difference in G-proteincoupled pathway is specific to GABA B R subunits.
It is worth noting that proteins involved in glutamatergic signaling, such as NMDAR, AMPAR, mGluR5, vGluT1, and vGluT2, remained unchanged in the PFC of APP −/− compared with WT mice (Fig. 6G-H) .
Normal PFC-Related Behaviors in APP −/− Mice PFC has been shown to play important roles in social activities (Yizhar et al. 2011; Ferenczi et al. 2016) . We next examined if altered GABAergic signaling in PFC would result in abnormal social interaction in the absence of APP. However, no significant difference was observed in between APP −/− and WT mice ( Supplementary Fig. 2 ).
Discussion
Neural network activity of PFC pyramidal neurons is a central feature of working memory and input to these pyramidal neurons from diverse classes of GABAergic interneurons is considered essential for providing spatial and temporal specificity in the encoding and maintaining of memory-related information (Goldman-Rakic 1995; Arnsten 2013) . Deposition of the APP cleavage product, Aβ, in the medial PFC correlates significantly with impaired memory consolidation from hippocampus to neocortex (Mander et al. 2015) and elicits neural network dysfunction, a feature of AD brain in both mouse models and AD patients (Palop et al. 2006; Verret et al. 2012) . Though deletion of an APP homolog, APLP2, showed only subtle effects on the fine-tuning of network oscillations in hippocampal slices (Zhang et al. 2013) , how the endogenous function of APP relates to the regulation of cortical network activity, which is fundamental for cognitive processes (Hahn et al. 2012) , has been unclear. In this study, we showed that APP deficiency results in hyperexcitability of neural network activity as revealed by prolonged UP-state duration in the PFC of APP −/− mice. Our finding demonstrates, for the first time, a critical role for APP in mediating cortical neural network activity. The involvement of GABA A Rs in network activity and neurodegenerative disease has been studied in great detail. Altered GABAergic function, especially via GABA A Rs, has been reported in AD patients as well as transgenic AD mouse models (Limon et al. 2012; Liang et al. 2014) . The role of glutamatergic excitation and GABA A R-mediated fast GABAergic inhibition in UDS has also been reported (Sanchez-Vives and McCormick 2000; Compte et al. 2003; Mann et al. 2009 ). In contrast, the function of GABA B R at the network level is only just starting to emerge. Thus, termination of UP states by GABA B R activation has been demonstrated in several brain areas, including PFC (Wang et al. 2010; Craig and McBain 2014) , but there is currently relatively little information about the molecules and pathways that are critically involved in the regulation of GABA B R signaling. We demonstrated in this study that APP is important in regulating GABA B R expression and function through modification of GS, and consequently in regulating neural network activity. It is worth noting that in line with unchanged GABA A R protein levels, GABA A R function evaluated by SD analysis (Mann et al. 2009) (Supplementary Fig. 3 ) is not changed in APP −/− compared with WT controls, providing a good opportunity for us to use chloral hydrate, which activates GABA A R (Lu and Greco 2006) as anesthetic in recording UDS in this study. Furthermore, protein levels of glutamatergic transporters and receptors, including mGluR5 that showed abnormality in the regulation of UP-state duration in fragile X-deficient mice (Hays et al. 2011) , are similar in APP −/− and WT, suggesting normal GABA A R-mediated inhibition and excitatory synaptic protein activity in the PFC of APP −/− mice. From these data, it becomes apparent that impaired GABA B R signaling, downstream of GS reduction, is responsible for perturbation of the excitation/inhibition ratio (E/I) and thus the hyperexcitability that leads to prolonged UPstate duration in the PFC of APP −/− mice. . Each value represents the mean ± SEM. *P < 0.05, **P < 0.01; two-sample two-tailed Student's t-test.
GABA B1 Rs containing the GABA B1a subunit are predominantly found in the presynaptic terminals of both excitatory and inhibitory synapses, where they function to reduce the release of glutamate and GABA (Thompson et al. 1993; Wu and Saggau 1997) , while those containing the GABA B1b subunit are predominantly located in postsynaptic compartments (Perez-Garci et al. 2006; Vigot et al. 2006) , an observation that holds for all excitatory synapses examined throughout the CNS, including the PFC (Isaacson et al. 1993; Gassmann and Bettler 2012) . Though GABA B1 R levels were significantly increased in the PFC of APP −/− mice, GABA B1a R expression remained similar in WT and in APP −/− mice. This suggests that presynaptic GABA B Rmediated function is unlikely changed in APP −/− PFC.
Activation of postsynaptic GABA B Rs, which occurs during periods of synchronous activity including UDS (Xu et al. 2008; Kohl and Paulsen 2010) , results in inhibition of neuronal activity by generation of hyperpolarizing postsynaptic potentials via GIRKs (Dutar and Nicoll 1988; Perez-Garci et al. 2006; Labouebe et al. 2007 ). In line with these reports of GABA B R-mediated hyperpolarization, we observed that Bac treatment causes a significant negative shift in the intracellularly recorded DOWNstate membrane potential in APP −/− but not in WT mice (Fig. 2 Fig. 6A-B) , the results suggest that reduced GABA levels in the synaptic cleft of APP −/− PFC might be attributed to a reduction in GS-mediated GABA synthesis but not to a reduction in numbers of GABAergic interneuron or impaired presynaptic GABA B1a R-mediated GABA release. It has been shown that acute disturbance of the E/I balance in the PFC led to impairment of social interaction in mice (Yizhar et al. 2011) . While APP −/− mice did not demonstrate abnormal social behavior in this study, we reason that APP deletion-induced E/I imbalance was chronic and therefore APP −/− mice might develop ways, that is, GABA B R upregulation, to compensate for the impairment, or the mice we used were too young (1-2 months) to display abnormal social interaction. We also evaluated if APP overexpression would lead to altered UDS as well. Using APP/PS1 mouse model (Jankowsky et al. 2001) , we observed significantly increased DOWN-state duration suggesting an enhanced inhibition ( Supplementary  Fig. 4 ) accompanied by reduced GABA B R levels and identical GABA content in the PFC of APP/PS1 mice ( Supplementary Fig.  5 ). It is worth noting that upregulation of inhibitory activity in the PFC of APP overexpression mice was associated with reduced GABA B R levels that is opposite to APP −/− mice in which we observed increased GABA B R expression.
In conclusion, this work demonstrates that APP deficiency results in aberrant GS and downstream GABA B R expression and GABA B R-mediated postsynaptic inhibition in the PFC. Although how APP deficiency gives rise to reduction in GS remains unclear, this study offers an integrated biophysical, pharmacological, and neurochemical explanation for how APP modulates PFC neural network activity. In addition, our data suggest GABA B R as a potential therapeutic target in pathological conditions where cortical neural network activity is disturbed. Given that memory procession during SWS requires the activity of neural networks involving PFC, knowing how PFC oscillatory activity is regulated by APP will provide, in addition to information on the physiological roles of APP, both a basis for understanding the molecular and cellular mechanisms underlying cortical network function and an insight into understanding the pathogenesis and treatment of cortical network dysfunction in AD.
